This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Feldman, Steven
| Item Type | Name |
|
Academic Article
|
Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period.
|
|
Academic Article
|
Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
|
|
Academic Article
|
Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
|
|
Academic Article
|
Tacrolimus ointment: utilization patterns in children under age 2 years.
|
|
Academic Article
|
Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
|
|
Academic Article
|
Sun protection strength of a hydroquinone 4%/retinol 0.3% preparation containing sunscreens.
|
|
Academic Article
|
Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis.
|
|
Academic Article
|
Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
|
|
Academic Article
|
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Academic Article
|
Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States.
|
|
Academic Article
|
Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis.
|
|
Academic Article
|
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.
|
|
Academic Article
|
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.
|
|
Academic Article
|
Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis.
|
|
Academic Article
|
Tildrakizumab: A Review of Phase II and III Clinical Trials.
|
- Dose Response Relationship Drug